Novo Nordisk Faces Mounting Challenges as Competition Intensifies
Novo Nordisk cuts 2026 sales outlook amid generic competition in India, U.S. price pressures, and Eli Lilly’s new…
Novo Nordisk Shares Find Support in Wegovy Pill Data
Novo Nordisk’s oral Wegovy shows greater weight loss & better tolerability vs. Eli Lilly’s Foundayo in new data,…
Novo Nordisk Navigates Pricing Pressures with Strategic Pivot
Novo Nordisk slashes prices in some markets and launches Wegovy subscriptions as new clinical data shows edge over…
Novo Nordisk Navigates Pricing Pressures with Strategic Pivot
Novo Nordisk slashes prices in some markets and launches Wegovy subscriptions as new clinical data shows edge over…
Novo Nordisk Launches Aggressive Pricing Strategy for Wegovy Amid Restructuring
Novo Nordisk introduces a $249/month Wegovy subscription to boost patient loyalty and undercut Eli Lilly, while cutting 400…
Novo Nordisk Slashes U.S. Drug Prices in Competitive Countermove
Novo, Nordisk
26.03.2026 – 03:56:40 | boerse-global.de
Novo Nordisk cuts U.S. prices for Ozempic…
Novo Nordisk Faces Mounting Pressure as Rival Gains Ground
Novo Nordisk faces intense competition from Eli Lilly in the $100B obesity drug market, with clinical data and…